What is the recommended treatment for acute group A streptococcal pharyngitis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 2, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Recommended Treatment for Strep Throat

For patients without penicillin allergy, prescribe oral amoxicillin 50 mg/kg once daily (maximum 1000 mg) or 25 mg/kg twice daily (maximum 500 mg per dose) for a full 10-day course. 1, 2

First-Line Therapy for Non-Allergic Patients

  • Amoxicillin is the preferred first-line agent because no documented penicillin resistance exists worldwide among Group A Streptococcus, guaranteeing reliable bacterial eradication. 1, 2
  • Amoxicillin offers better palatability than penicillin V in children, once- or twice-daily dosing improves adherence, and it has identical efficacy to penicillin V. 1, 2
  • Penicillin V is an equally effective alternative: 250 mg 2-3 times daily for children or 500 mg twice daily for adults, both for 10 days. 1, 2
  • Intramuscular benzathine penicillin G (600,000 IU for <27 kg; 1.2 million IU for ≥27 kg) as a single dose is recommended when oral adherence cannot be assured. 1

Critical Treatment Duration

  • A complete 10-day antibiotic course is mandatory to achieve maximal pharyngeal eradication and prevent acute rheumatic fever; shortening the course by even 2-3 days markedly increases treatment failure and rheumatic fever risk. 1, 3, 2
  • Even though symptoms typically resolve within 3-4 days, the organism persists in the pharynx and premature discontinuation permits bacterial regrowth. 1
  • The primary goal is prevention of acute rheumatic fever and suppurative complications (peritonsillar abscess, cervical lymphadenitis), not merely symptom relief. 1, 2

Management of Penicillin Allergy

Non-Immediate (Delayed) Reactions

  • First-generation cephalosporins are the preferred alternatives with strong, high-quality evidence; cross-reactivity risk is only 0.1% in patients with delayed, mild penicillin reactions. 1, 3
  • Cephalexin: 500 mg twice daily for 10 days (adults) or 20 mg/kg twice daily (maximum 500 mg per dose) for 10 days (children). 1, 3
  • Cefadroxil: 1 g once daily for 10 days (adults) or 30 mg/kg once daily (maximum 1 g) for 10 days (children). 1

Immediate/Anaphylactic Reactions

  • All β-lactam antibiotics must be avoided because cross-reactivity can reach 10% in patients with immediate hypersensitivity (anaphylaxis, angioedema, urticaria within 1 hour). 1, 3, 2
  • Clindamycin is the preferred non-β-lactam alternative: 300 mg three times daily for 10 days (adults) or 7 mg/kg three times daily (maximum 300 mg per dose) for 10 days (children). 1, 3, 2
  • Clindamycin has only ~1% resistance among U.S. Group A Streptococcus isolates and demonstrates superior eradication even in chronic carriers and treatment failures. 1, 3, 2
  • Azithromycin: 500 mg once daily for 5 days (adults) or 12 mg/kg once daily (maximum 500 mg) for 5 days (children)—the only antibiotic requiring just 5 days due to prolonged tissue half-life. 1, 3, 4
  • Clarithromycin: 250 mg twice daily for 10 days (adults) or 7.5 mg/kg twice daily (maximum 250 mg per dose) for 10 days (children). 1
  • Macrolides are less preferred because resistance ranges from 5-8% in the United States and varies geographically; clindamycin is more reliable. 1, 3, 4

Resistance Patterns and Antibiotic Selection

  • Penicillin/amoxicillin: 0% resistance worldwide. 1, 2
  • First-generation cephalosporins: Essentially 0% resistance. 1
  • Clindamycin: ~1% resistance in the United States. 1, 3
  • Macrolides (azithromycin, clarithromycin): 5-8% resistance in the United States, higher in some regions. 1, 3, 4

Management of Treatment Failure

  • If symptoms persist after a fully adhered 10-day course, switch to clindamycin (300 mg three times daily for 10 days in adults; 7 mg/kg three times daily for 10 days in children) to achieve higher eradication rates. 1
  • Clindamycin is substantially more effective than penicillin or amoxicillin in eliminating chronic streptococcal carriage. 1
  • Amoxicillin-clavulanate (40 mg amoxicillin/kg/day divided three times daily, maximum 2000 mg amoxicillin/day) for 10 days is an alternative for chronic carriers or treatment failures. 1

Adjunctive Symptomatic Management

  • Acetaminophen or ibuprofen should be offered for moderate-to-severe sore throat, fever, or systemic discomfort. 1, 3
  • Aspirin must be avoided in children due to the risk of Reye syndrome. 1, 3
  • Corticosteroids are not recommended as adjunctive therapy. 1, 3

Common Pitfalls to Avoid

  • Do not shorten the antibiotic course below 10 days (except azithromycin's 5-day regimen), as this dramatically increases treatment failure and rheumatic fever risk. 1, 3, 2
  • Do not use cephalosporins in patients with immediate/anaphylactic penicillin reactions because of the ~10% cross-reactivity risk. 1, 3, 2
  • Do not prescribe trimethoprim-sulfamethoxazole (Bactrim) for strep throat; it fails to eradicate Group A Streptococcus in 20-25% of cases. 1, 2
  • Do not use tetracyclines for streptococcal pharyngitis; they fail to eradicate the organism and do not prevent acute rheumatic fever. 1, 2
  • Routine post-treatment throat cultures are not indicated for asymptomatic patients who completed therapy; reserve testing for special circumstances such as history of rheumatic fever. 1, 3

Return to School or Work

  • Patients become non-contagious after 24 hours of appropriate antibiotic therapy and may return to school or work at that time. 1, 3

References

Guideline

Treatment of Streptococcal Infections in Patients with Penicillin Allergy

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Treatment of Streptococcus pyogenes Group A Infections

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Treatment of Strep Laryngitis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.